Related references
Note: Only part of the references are listed.Overexpression of apolipoprotein CIII increases and CETP reverses diet-induced obesity in transgenic mice
A. G. Salerno et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Cardiovascular actions of insulin
Ranganath Muniyappa et al.
ENDOCRINE REVIEWS (2007)
Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions
Chunyu Zheng et al.
JOURNAL OF LIPID RESEARCH (2007)
Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells
Francesco Andreozzi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
PPARα mediates the hypolipidemic action of fibrates by antagonizing FoxO1
Shen Qu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappa B activation
Akio Kawakami et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
PKCδ-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function
Michael W. Greene et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells
Akio Kawakami et al.
CIRCULATION (2006)
Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase
Xing Li Wang et al.
DIABETES (2006)
Reciprocal relationships between insulin resistance and endothelial dysfunction - Molecular and pathophysiological mechanisms
JA Kim et al.
CIRCULATION (2006)
Activation of vascular protein kinase C-β inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance
K Naruse et al.
DIABETES (2006)
Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells
A Kawakami et al.
CIRCULATION (2006)
Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome
T Nakamura et al.
ATHEROSCLEROSIS (2005)
Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity
JS Cohn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Apolipoprotein CIII promotes Ca2+-dependent β cell death in type 1 diabetes
L Juntti-Berggren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Lipoprotein remnants and endothelial dysfunction in the postprandial phase
FM Maggi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism
J Altomonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Protein kinase C (PKC) beta modulates serine phosphorylation of insulin receptor substrate-1 (IRS-1) - Effect of overexpression of PKC beta on insulin signal transduction
T Ishizuka et al.
ENDOCRINE RESEARCH (2004)
Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemia
MA Mansoor et al.
CLINICAL BIOCHEMISTRY (2004)
Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation
A Kawakami et al.
CIRCULATION (2003)
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease
O Olivieri et al.
JOURNAL OF LIPID RESEARCH (2003)
Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions
A Kawakami et al.
CIRCULATION RESEARCH (2002)
Plasma glucose regulation and insulin secretion in hypertriglyceridemic mice
MEC Amaral et al.
HORMONE AND METABOLIC RESEARCH (2002)